+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID04457544

Swiss National Registry for Spontaneous Coronary Artery Dissection SCAD Observing Outcomes and Treatments in Adults 18 Years and Older

Led by Dr. Sophie Degrauwe · Updated on 2022-11-16

1000

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What this Trial Is About

Spontaneous coronary artery dissection SCAD is a condition that mainly affects young women without typical heart disease risk factors and can lead to serious problems like heart attack or cardiac arrest. Despite advances in diagnosis, SCAD is still not well understood or well studied. This research involves the SwissSCAD registry, a large observational study designed to track the natural course of SCAD, its outcomes, and how it is treated. The study includes two groups one made up of patients diagnosed with SCAD in the past five years, whose hospital records will be reviewed retrospectively, and another group of patients newly diagnosed with SCAD who will be followed prospectively. Each patient will be informed about the study and given at least one week to decide on participation. The goal is to include 500 patients in each group. Participants will undergo clinical follow-up to monitor safety events such as heart problems at 30 days, 1 year, and 5 years after diagnosis. Researchers will review medical records and outcomes to better understand SCADs progression and treatment effectiveness. The study is led by Dr. Sophie Degrauwe and participants will be observed over several years to gather important data on safety and health outcomes.

CONDITIONS

Brief Title

Spontaneous Coronary Artery Dissection National Swiss Registry

Research Team

S

Sophie Degrauwe, Dr

V

Veronique Menoni, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here